This article has Open Peer Review reports available.
Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia – identification of responders by gene expression profiling of pretreatment leukemic cells
© The Author(s). 2017
Received: 18 July 2016
Accepted: 28 August 2017
Published: 6 September 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|18 Jul 2016||Submitted||Original manuscript|
|31 Jan 2017||Reviewed||Reviewer Report - Rotraud Wieser|
|17 May 2017||Reviewed||Reviewer Report - Lars Bullinger|
|17 Jun 2017||Author responded||Author comments - Håkon Reikvam|
|Resubmission - Version 2|
|17 Jun 2017||Submitted||Manuscript version 2|
|21 Jun 2017||Reviewed||Reviewer Report - Rotraud Wieser|
|2 Jul 2017||Reviewed||Reviewer Report - Lars Bullinger|
|9 Aug 2017||Author responded||Author comments - Håkon Reikvam|
|Resubmission - Version 3|
|9 Aug 2017||Submitted||Manuscript version 3|
|24 Aug 2017||Author responded||Author comments - Håkon Reikvam|
|Resubmission - Version 4|
|24 Aug 2017||Submitted||Manuscript version 4|
|28 Aug 2017||Editorially accepted|
|6 Sep 2017||Article published||10.1186/s12885-017-3620-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.